Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Klein Vision unveils production prototype of the AirCar 2025-05-08 15:00
Rishabh Software and S4G Consulting Launch SR360 to Accelerate Digital Transformation in Australia 2025-05-08 08:30
Bellroy, the popular Australian carry brand, releases much-anticipated luggage styles 2025-05-07 07:10
Blinq Raises $25M Series A to Reimagine the Start of Every Professional Relationship 2025-05-07 06:34
Sigenergy Becomes Australia's Top Battery Brand by Market Share, SunWiz Reports 2025-04-28 12:27
FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous EEG Monitor Approved in US 2025-04-23 06:15
Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano 2025-04-17 21:01
SECuRE trial update: First patient treated in the Phase II Cohort Expansion 2025-04-15 21:02
CUBE LAUNCHES REGPLATFORM™ INTEL TO TRANSFORM THE MID-MARKET REGULATORY INTELLIGENCE LANDSCAPE IN FINANCIAL SERVICES 2025-04-09 14:00
Hydrexia and Pure Hydrogen Sign Commercial Agreement in Australia 2025-04-07 21:00
Bonnell Electric Unleashes the 775 Series: The Future of Electric Performance is Here 2025-04-01 23:30
Seeing Machines Announces 3D Camera Technology for Next-Generation In-Cabin Monitoring Systems 2025-04-01 22:20
Canadian Solar and Flow Power to Install Innovative Anti-Hail Solar Panels 2025-04-01 19:00
ECHO IQ SIGNS STRATEGIC PARTNERSHIP AND INTEGRATION AGREEMENTS WITH SCIMAGE AND MEDAXIOM TO EXPAND ECHOSOLV AS ACROSS 36 US CARDIOLOGY NETWORKS 2025-04-01 13:39
NEURIM PHARMACEUTICALS RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR PEDIATRIC PROLONGED-RELEASE MELATONIN (SLENYTO®) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) 2025-03-26 17:00
Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I NMIBC Trial, Data Presented at EAU 2025 2025-03-24 20:30
Seeing Machines announces new technology and safety appointments 2025-03-24 15:00
GCF Global Research Amplifies Movie-Goers' Voices: They Want More 2025-03-20 02:00
CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL 2025-03-06 08:10
SECuRE trial update: 92% of pre-chemo participants experience greater than 35% drop in PSA levels across all cohorts. Cohort Expansion Phase commences. 2025-03-05 21:44
1 3 4 5 6 7 120